Search
Support us
  • RESEARCH
  • PUBLICATIONS
  • PUBLISHER CORRECTION: CLINICAL EFFICACY AND BIOMARKER ANALYSIS OF NEOADJUVANT ATEZOLIZUMAB IN OPERABLE UROTHELIAL CARCINOMA IN THE ABACUS TRIAL.

Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.

  • Show more authors
    + 22
  • Thomas Powles
  • Mark Kockx
  • Alejo Rodriguez-Vida
  • Ignacio Duran
  • Simon J Crabb
  • Michiel S Van Der Heijden
  • Bernadett Szabados
  • Albert Font Pous
  • Gwenaelle Gravis
  • Urbano Anido Herranz
  • Andrew Protheroe
  • Alain Ravaud
  • Denis Maillet
  • Maria Jose Mendez
  • Cristina Suarez
  • Mark Linch
  • Aaron Prendergast
  • Pieter-Jan van Dam
  • Diana Stanoeva
  • Sofie Daelemans
  • Sanjeev Mariathasan
  • Joy S Tea
  • Kelly Mousa
  • Romain Banchereau
  • Daniel Castellano

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

More about this publication

Nature medicine
  • Volume 26
  • Issue nr. 6
  • Pages 983
  • Publication date 01-06-2020
Full text links

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.